StoxCaplin Point Laboratories vs Vijaya Diagnostic Centre: share price & financials comparison
NSE: CAPLIPOINT vs VIJAYA · Healthcare · as of 13 Nov 2026
Both prices rebased to 100 at the start of the selected period.
Caplin Point Laboratories vs Vijaya Diagnostic Centre at a glance
Caplin Point Laboratories (CAPLIPOINT) has a market capitalisation of ₹18,154 Cr, against ₹14,524 Cr for Vijaya Diagnostic Centre (VIJAYA). Over the past year Vijaya Diagnostic Centre has returned +37.5%, compared with +19.7% for Caplin Point Laboratories. On valuation, Caplin Point Laboratories trades at a lower P/E of 26.3 versus 71.3. Vijaya Diagnostic Centre earns a higher return on equity (19.3% vs 17.7%). Caplin Point Laboratories comes out ahead on size and valuation. Vijaya Diagnostic Centre comes out ahead on profitability, growth, momentum and technicals. Across the scored metrics below, Caplin Point Laboratories leads on 8 and Vijaya Diagnostic Centre on 8. On StoxGud's 10-point checklist, Caplin Point Laboratories scores 9/10 and Vijaya Diagnostic Centre scores 8/10.
| Metric | Caplin Point Laboratories | Vijaya Diagnostic Centre |
|---|---|---|
| Size | ||
| Market cap | ₹18,154 Cr | ₹14,524 Cr |
| Revenue (latest FY) | ₹2,187 Cr | ₹814 Cr |
| Net profit (latest FY) | ₹641 Cr | ₹173 Cr |
| Valuation | ||
| P/E | 26.3 | 71.3 |
| P/B | 4.65 | 13.74 |
| Dividend yield | 0.25% | 0.14% |
| Profitability | ||
| Return on equity | 17.7% | 19.3% |
| Net profit margin | 28.9% | 22.4% |
| Operating margin | 34.9% | 43.1% |
| Growth | ||
| Revenue growth (YoY) | +17.9% | +26.7% |
| Net profit growth (YoY) | +15.3% | +37.4% |
| Revenue CAGR (multi-year) | +15.6% | +15.2% |
| Financial health | ||
| Debt to equity | 0.00 | 0.00 |
| Momentum | ||
| 1-month return | +1.1% | +0.3% |
| 1-year return | +19.7% | +37.5% |
| 3-year CAGR | +23.7% | +31.3% |
| 5-year CAGR | +22.7% | +20.0% |
| 10-year CAGR | +21.3% | — |
| Distance from 52W high | -16.7% | -10.2% |
| Technicals | ||
| RSI (14) | 64 | 54 |
| Price vs 200-day avg | +9.1% | +12.5% |
Highlighted cells lead on that metric. Market cap, revenue and RSI are shown for context and not scored.
10-point checklist side by side
| Check | Caplin Point Laboratories | Vijaya Diagnostic Centre |
|---|---|---|
| Price above 50-day average | ✗ | ✗ |
| Price above 200-day average | ✓ | ✓ |
| 50-day average above 200-day (uptrend) | ✓ | ✓ |
| RSI in healthy 40–70 zone | ✓ | ✓ |
| Positive 1-year return | ✓ | ✓ |
| Return on equity above 15% | ✓ | ✓ |
| Debt to equity below 1 | ✓ | ✓ |
| Revenue growing year on year | ✓ | ✓ |
| Net profit margin above 10% | ✓ | ✓ |
| P/E below industry median | ✓ | ✗ |
| Score | 9/10 | 8/10 |
A rules-based screen for education only — not a buy or sell recommendation.
FAQs
Which is bigger, Caplin Point Laboratories or Vijaya Diagnostic Centre?
Caplin Point Laboratories has a market cap of ₹18,154 Cr and Vijaya Diagnostic Centre has a market cap of ₹14,524 Cr as of 13 Nov 2026.
Which has a lower P/E, Caplin Point Laboratories or Vijaya Diagnostic Centre?
Caplin Point Laboratories has the lower P/E: Caplin Point Laboratories trades at 26.3 and Vijaya Diagnostic Centre at 71.3.
Which gave better returns in the last year, Caplin Point Laboratories or Vijaya Diagnostic Centre?
Vijaya Diagnostic Centre did better: Caplin Point Laboratories returned +19.7% and Vijaya Diagnostic Centre returned +37.5% over one year.
What is the difference between Caplin Point Laboratories and Vijaya Diagnostic Centre?
Both are NSE-listed companies in Healthcare. Caplin Point Laboratories is about 1.2 times the size of Vijaya Diagnostic Centre by market cap. In the latest financial year Caplin Point Laboratories reported revenue of ₹2,187 Cr and Vijaya Diagnostic Centre ₹814 Cr. Operating margin is 34.9% for Caplin Point Laboratories and 43.1% for Vijaya Diagnostic Centre. Debt to equity is 0.00 for Caplin Point Laboratories and 0.00 for Vijaya Diagnostic Centre.
Which is better, Caplin Point Laboratories or Vijaya Diagnostic Centre?
It depends on what you are looking for, and StoxGud does not recommend either stock. On the metrics compared above, Caplin Point Laboratories leads on 8 and Vijaya Diagnostic Centre on 8. Caplin Point Laboratories is ahead on size and valuation. Vijaya Diagnostic Centre is ahead on profitability, growth, momentum and technicals. On StoxGud's rules-based checklist Caplin Point Laboratories scores 9/10 and Vijaya Diagnostic Centre scores 8/10. This is information, not advice: consult a SEBI-registered adviser before investing.